Date: Wednesday, November 16, 2022
An Exploration of USP Chapter 797 revisions and their impact on pharmacy regulatory and compliance efforts.
CPS invites you to watch this roundtable discussion between experts from our Clinical Program Development team to explore priority topics currently influencing pharmacy practice. Attendees learned about initiatives driving value for our clinical and operational teams. We invite you to consider how similar work and partnerships may benefit caregivers, patients, and staff at your sites of care.
Attendees will explore:
Audience members explored:
• Strategies for cost savings and the adoption of biosimilars
• Vaccine resources for preventable diseases
• Approaches to generating clinical initiatives of value
• The Joint Commission, COVID standards, and approaching changing regulations
Presenters:
Rabiah Dys
Pharm.D., R.Ph.
Senior Vice President, Clinical Services and Program Development
CPS
Valerie Sheehan
Pharm.D., R.Ph.
Vice President, Clinical Program Development
CPS
Michaela Park
Pharm.D., R.Ph.
Specialist, Clinical Program Development
CPS